Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

Mise à jour : Il y a 4 ans
Référence : NCT00204308

Femme Homme

  • | Pays :
  • Zambia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine whether the addition of tenofovir (TDF) and emtricitabine (FTC)to a standard PMTCT regimen containing single-dose nevirapine (NVP) can reduce the development of post-ingestion HIV resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs).


Critère d'inclusion

  • HIV ,pregnancy

Liens